Data obtained was analyzed using Agilent Mass Hunter Qualitative Analysis software to identify the most regulated metabolite following ranibizumab treatment. stored in liquid nitrogen to snap freeze the metabolites that were present in the samples. 2.3. Metabolite Extraction The cell pellet stored in liquid nitrogen was thawed at room temperature and then transferred into a microcentrifuge tube. Distilled water (dH2O) with pH 10 was added into each tube followed by the addition of absolute methanol (Sigma Aldrich, Saint Louis, MO, USA). The cell suspension was agitated in a tube shaker for 20 min at 11,000 with 4 C. After centrifugation, different layers were separated. Polar metabolites were extracted in upper layer and the nonpolar metabolites were extracted in the lower layer. The upper layer and lower layer were collected and transferred to new 2 mL centrifuge tube and mixed thoroughly. The samples were then dried at 0 C KRas G12C inhibitor 3 for 120 min using an Eppendorf Concentrator Plus and were vortex-mixed for one minute before they were finally transfer into vials for LC/MS analysis. 2.4. LC/MS Q-TOF Analysis and Data Processing A 1 L sample was injected splitless into an Agilent 6520 Q-TOF liquid chromatography/mass spectrometer (LC/MS) system (Agilent Technologies, Santa Clara, CA, USA) equipped with dual-ESI source. Zobrax Eclips Plus C18-ID of 1 1.8 m particle size and 2.1 100 mm column dimension was used. The heat was maintained at 40 C during the run. The mobile phase consisted of two main components: (A) 0.1% formic acid in water and (B) 0.1% formic acid in acetonitrile. The flow rate was set at 0.25 mL/minutes and the injection volume was 2 L. A linear gradient was developed over 36 min from 5% to 95% of KRas G12C inhibitor 3 mobile phase (B). Total run time was 48 min for each analysis. ESI Source setting was as follows: V Cap 4000 V, skimmer 65 V, and fragmentor 125 V. The mass spectral acquisition ranger was set from 50 to 1400 mass to charge ratio (m/z). The nebulizer was set at 45 pounds per square gauge (psig) and the nitrogen drying was set at flow rate of 12 L/minutes. Drying gas heat was maintained at 350 C. Data was acquired at rate of 2.5 spectra/seconds with a stored range of m/z 50C1000. Internal reference ions were used to correct mass accuracy. Autocalibration parameters were chosen to average ten scans and reference mass correction was enabled throughout the run. In order to obtain profiles containing as many as possible of this untargeted study, the generic setting was chosen for both LC separation and MS analysis. Continuous internal calibration was done to assure the desired mass accuracy of the recorded ions. Agilent Mass Hunter Qualitative Analysis Software B.05.00 (Agilent Technologies, Santa Clara, CA, USA, 2011) was used to process the data after it had been collected by Agilent Mass Hunter Workstation Data Acquisition Software B.02.01 (Agilent Technologies, Santa Clara, CA, USA, 2011). Data was presented by total ion chromatogram (TIC). Minimum absolute abundance was set at 1000. The identification of the metabolites was done by using Mass Profile Professional (MPP) Software version B.12.01 (Agilent Technologies, Santa Clara, CA, USA). The metabolites that could not be identified were excluded from further analysis while the identified ones were collected and processed for further recursive analysis. Further analysis was done by analysis of variance (ANOVA), theory component analysis (PCA), and clustering test. Data Rabbit polyclonal to Caspase 6 mining was performed by the molecular feature extractor (MFE) algorithm in the Agilent Mass Hunter Workstation Software B.07.00 (Agilent Technologies, Santa Clara, CA, USA, 2013). Noise was removed by using relative height parameter which was set at 1% of largest peak. The setting was applied for data processing method and used to process all generated data files in batch mode. Compound exchange format file was created for each sample and subjected to further data filtering and statistical analysis by MPP. Each sample was analyzed in triplicate with four biological replicates. The filter (frequency analysis) was performed KRas G12C inhibitor 3 to determine the compounds that were present 100% of the time in at least one studied group. Filtering by ANOVA was the next step in selecting entities that are of significant values. In order to identify metabolites with differences in abundance between the experimental groups,.